Publications by authors named "Sarah S Stith"

Article Synopsis
  • The study investigates the connection between patients’ subjective feelings of being "high" and their treatment outcomes during real-time cannabis usage, using data from the Releaf App™ involving 1,882 users over several years.
  • Patients reported feeling high in almost half of their sessions, and these instances were linked with a notable 7.7% decrease in symptom severity compared to sessions where they didn’t feel high.
  • THC levels and dosage were the main factors for feeling high, while using a vaporizer reduced this feeling; the study found significant associations for pain, anxiety, depression, and fatigue relief but not for insomnia.
View Article and Find Full Text PDF

Background: Little is known about the frequency with which different combinations of phytochemicals (chemovars) arise in Cannabis flower or whether common chemovars are associated with distinct pharmacodynamics and patient health outcomes. This study created a clinically relevant, user-friendly, scalable chemovar indexing system summarizing primary cannabinoid and terpene contents and tested whether the most frequently consumed chemovars differ in their treatment effectiveness and experienced side effects.

Methods: Between 09/10/2016 and 03/11/2021, 204 people used the freely available, educational mobile software application, Releaf App, to record 6309 real-time consumption sessions using 633 distinct Cannabis flower products, unique at the user level, with terpene and cannabinoid potency information.

View Article and Find Full Text PDF
Article Synopsis
  • Legalization of cannabis in U.S. states has led to an increase in its use as an alternative to traditional pharmaceutical drugs.
  • Stock market returns for generic and brand pharmaceutical companies dropped by 1.5-2% within 10 days following legalization events between 1996 and 2019.
  • Investors expect an average annual sales reduction of $3 billion for drugmakers after a single cannabis legalization event.
View Article and Find Full Text PDF

Unlabelled: The COVID-19 pandemic represents a major threat to health and economic well-being in the USA, especially for older and disabled workers, and may spill over onto Social Security. We use individual-level from the Current Population Survey, state-level monthly Social Security administrative data on disability benefit applications, and national-level monthly data on Social Security retirement benefit applications to assess the impact of the pandemic on older adults' employment and benefit claiming. State-level monthly Google Trends data are used as a leading indicator of future claiming in the population.

View Article and Find Full Text PDF

Objectives: We measure for the first time how commercially available flower products affect feelings of fatigue.

Methods: A total of 1,224 people recorded 3,922 flower self-administration sessions between June 6, 2016, and August 7, 2019, using the Releaf App. Usage sessions included real-time subjective changes in fatigue intensity levels prior to and following consumption, flower characteristics (labeled phenotype, cannabinoid potency levels), combustion method, and any potential experienced side effects.

View Article and Find Full Text PDF

The existing literature largely focuses on health risks and other pharmacodynamics of using cannabis, with fewer investigations of other normative psychological effects from consumption among otherwise healthy people. We measured several basic constructs of social psychology corresponding to the concept of prosociality among 146 healthy young adults between 18 and 25 years (M = 18.9, SD = 1.

View Article and Find Full Text PDF

Goals: We measure for the first time how a wide range of cannabis products affect nausea intensity in actual time.

Background: Even though the Cannabis plant has been used to treat nausea for millennia, few studies have measured real-time effects of common and commercially available cannabis-based products.

Study: Using the Releaf App, 886 people completed 2220 cannabis self-administration sessions intended to treat nausea between June 6, 2016 and July 8, 2019.

View Article and Find Full Text PDF

Background: An observational research design was used to evaluate which types of commonly labeled Cannabis flower product characteristics are associated with changes in momentary feelings of distress-related symptoms.

Methods: We used data from 2306 patient-directed cannabis administration sessions among 670 people who used the real-time Cannabis effects recording software, Releaf App, between June 6, 2016, and February 23, 2019, for tracking the effects of Cannabis flower consumption. Fixed effects multivariable panel regression techniques were used to establish overall relief by symptom type and to determine which labeled product characteristics (e.

View Article and Find Full Text PDF

Policies increasing healthcare availability might decrease the cost of delaying accessing of care, leading to potential negative consequences if patients delay treatment. We analyze a policy designed to increase access to kidney transplantation through the use of time since dialysis inception to prioritize patients for transplant, which was piloted at 26 of the 271 kidney transplant centers in the United States in 2006 and 2007. We model the patient's optimization problem comparing the benefits and costs of early waitlisting and predict that the policy change will lead to delayed waitlisting.

View Article and Find Full Text PDF

Objective: Few studies to date have measured the real-time effects of consumption of common and commercially available Cannabis products for the treatment of headache and migraine under naturalistic conditions. This study examines, for the first time, the effectiveness of using dried Cannabis flower, the most widely used type of Cannabis product in the United States, in actual time for treatment of headache- and migraine-related pain and the associations between different product characteristics and changes in symptom intensity following Cannabis use.

Methods: Between 06/10/2016 and 02/12/2019, 699 people used the Releaf Application to record real-time details of their Cannabis use, including product characteristics and symptom intensity levels prior to and following self-administration; data included 1910 session-level attempts to treat headache- (1328 sessions) or migraine-related pain (582 sessions).

View Article and Find Full Text PDF

: Scientific research on how consumption of whole, natural flower affects low mood and behavioral motivations more generally is largely nonexistent, and few studies to date have measured how common and commercially available flower used may affect the experience of "depression" in real-time. : We observed 1,819 people who completed 5,876 cannabis self-administration sessions using the ReleafApp™ between 06/07/2016 and 07/08/2019, with the goal of measuring real-time effects of consuming flower for treating symptoms of depression. Results: On average, 95.

View Article and Find Full Text PDF

A pervasive viewpoint in health care is that higher patient volume leads to better outcomes, implying that facility volume can be used to identify high-quality providers. Hundreds of studies documenting a positive correlation between hospital volume and patient survival have motivated payers to use arbitrary minimum volume standards for elective surgical procedures, though it is unknown whether these policies actually improve patient outcomes. Using an instrumental variables approach, we show that minimum volume requirements in kidney transplantation do not reduce posttransplant mortality.

View Article and Find Full Text PDF
Article Synopsis
  • Self-assessed health is a popular metric used by economists, but it doesn’t always align with actual physical health outcomes.
  • This study indicates that psychological factors play a significant role in how individuals assess their health.
  • When concerns about the repeal of the Affordable Care Act (ACA) rose, low-income childless adults in states that expanded Medicaid reported a decline in their self-assessed health.
View Article and Find Full Text PDF
Article Synopsis
  • The study analyzes the impact of recreational cannabis access on the market share of over-the-counter sleep medications in Colorado counties from late 2013 to late 2014, using grocery store scanner data and multivariable regression.
  • Findings indicate a significant 236% decrease in the market share of sleep aids following the entry of dispensaries, particularly affecting diphenhydramine- and doxylamine-based products, while herbal sleep aids and melatonin remained less influenced.
  • The research suggests that many individuals may be using cannabis as an alternative treatment for insomnia despite sleep disturbances not being recognized as a qualifying condition for medical cannabis, highlighting the need for more studies on the effectiveness and side effects of both cannabis and
View Article and Find Full Text PDF
Article Synopsis
  • The study analyzed real-time data from nearly 3,000 users of the ReleafApp to understand how different cannabis products impact pain relief in various types of pain, examining over 20,000 cannabis usage sessions.
  • Results indicated that whole cannabis flower provided better pain relief compared to other cannabis products, with higher THC levels correlating strongly with increased analgesia and side effects, while CBD levels had little impact on overall pain relief.
  • The findings indicate that while cannabis therapy can be an effective mid-level treatment for pain, its effectiveness and the side effects experienced depend significantly on the specific characteristics of the cannabis product used.
View Article and Find Full Text PDF

Federal barriers and logistical challenges have hindered measurement of the real time effects from the types of cannabis products used medically by millions of patients in vivo. Between 06/06/2016 and 03/05/2018, 3,341 people completed 19,910 self- administrated cannabis sessions using the mobile device software, ReleafApp to record: type of cannabis product (dried whole natural Cannabis flower, concentrate, edible, tincture, topical), combustion method (joint, pipe, vaporization), Cannabis subspecies (C. indica and C.

View Article and Find Full Text PDF
Article Synopsis
  • The Releaf App gathered data from 2,830 users over 13,638 sessions to evaluate the self-reported effects and side effects of medical cannabis on various health symptoms.
  • Users reported significant reductions in symptom severity (between 2.8 and 4.6 points) for pain, anxiety, and depression, with those experiencing higher initial severity finding greater relief.
  • While most users experienced positive or context-specific side effects, negative side effects were more common among those treating depression and were linked to less symptom relief, highlighting the need for careful management of cannabis use.
View Article and Find Full Text PDF

Approximately 0.5% of the population is diagnosed with some form of schizophrenia, under the prevailing view that the pathology is best treated using pharmaceutical medications that act on monoamine receptors. We briefly review evidence on the impact of environmental forces, particularly the effect of autoimmune activity, in the expression of schizophrenic profiles and the role of therapy for regulating immunological functioning.

View Article and Find Full Text PDF

: We use a mobile software application (app) to measure for the first time, which fundamental characteristics of raw, natural medical flower are associated with changes in perceived insomnia under naturalistic conditions. : Four hundred and nine people with a specified condition of insomnia completed 1056 medical cannabis administration sessions using the Releaf App educational software during which they recorded real-time ratings of self-perceived insomnia severity levels prior to and following consumption, experienced side effects, and product characteristics, including combustion method, cannabis subtypes, and/or major cannabinoid contents of cannabis consumed. Within-user effects of different flower characteristics were modeled using a fixed effects panel regression approach with standard errors clustered at the user level.

View Article and Find Full Text PDF
Article Synopsis
  • The Scientific Registry of Transplant Recipients (SRTR) in the U.S. changed its rating system for transplant programs from 3 tiers to 5 tiers in 2016, classifying more programs as under-performing.
  • Over half of the 280 surveyed members of transplant organizations reported negative impacts from the new rating system, such as losing patients and insurers, and increased patient and provider concerns.
  • The transition to the 5-tier system has significantly influenced the transplant community, potentially affecting hospital finances and available patient options for transplantation in the long term.
View Article and Find Full Text PDF

The decision to authorize a patient for continued enrollment in a state-sanctioned medical cannabis program is difficult in part due to the uncertainty in the accuracy of patient symptom reporting and health functioning including any possible effects on other medication use. We conducted a pragmatic convenience study comparing patient reporting of previous and current prescription opioid usage to the opioid prescription records in the Prescription Monitoring Program (PMP) among 131 chronic pain patients (mean age = 54; 54% male) seeking the first annual renewal of their New Mexico Medical Cannabis Program (NMMCP) license. Seventy-six percent of the patients reported using prescription opioids prior to enrollment in the NMMCP, however, the PMP records showed that only 49% of the patients were actually prescribed opioids in the six months prior to enrollment.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the impact of the New Mexico Medical Cannabis Program (MCP) on opioid use among chronic pain patients, highlighting the need for alternative treatments amidst rising opioid addiction issues in the U.S.
  • Enrollment in the MCP significantly increased the odds of patients ceasing (17.27 times) and reducing opioid prescriptions compared to non-enrolled counterparts.
  • Patient feedback indicated notable improvements in pain management, quality of life, and minimal side effects associated with cannabis use after one year.
View Article and Find Full Text PDF
Article Synopsis
  • Co-prescribing of scheduled drugs is common in the U.S., raising health risks and healthcare system burdens.
  • A study compared prescription patterns of 83 chronic pain patients enrolled in New Mexico's Medical Cannabis Program (MCP) with 42 non-enrolled patients over a 24-month period.
  • Findings revealed that 34% of MCP patients stopped all scheduled medications, while the comparison group showed no change, indicating that legal cannabis access may lead to lower reliance on dangerous prescription drugs.
View Article and Find Full Text PDF

Organizational learning-by-doing implies that production outcomes improve with experience. Prior empirical research documents the existence of organizational learning-by-doing, but provides little insight into why some firms learn while others do not. Among the 124 U.

View Article and Find Full Text PDF

The goals of this study were to compare whether emergency department (ED) patients' pain intensity (PI) is measured differently by male and female nurses and to determine whether PI, heart rate (HR), and respiratory rate (RR) were used to prioritize patient urgency differently by male and female nurses. The associations between patients' PI|HR|RR and the Emergency Severity Index (ESI) scores they were assigned by attending nurses were analyzed using a national database of electronic medical records of US Veterans Affairs ED patients from 2008 to 2012. A total of 129,991 patients presenting for emergency care (Mage = 59.

View Article and Find Full Text PDF